Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Chemotherapy for Relapsed Lymphoid Malignancies
NCT00250718Phase 2Terminated
- Sponsor
- New Mexico Cancer Research Alliance
- Start
- Oct 2004
- Primary completion
- Nov 2008
- Modality
- Monoclonal Antibodies, Lipid-based Nanoparticles, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of etoposide, chlorambucil, vincristine sulfate liposome injection, dexamethasone, rituximab in non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), multiple myeloma (MM), chronic lymphocytic leukemia (CLL), sponsored by New Mexico Cancer Research Alliance. Started Oct 2004; status: terminated.
02
Drugs
etoposidechlorambucilvincristine sulfate liposome injectiondexamethasonerituximab
03
Conditions
non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)multiple myeloma (MM)chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00250718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00250718.